Healthcare Industry News: angioplasty balloon
News Release - May 5, 2008
Cordis Corporation Launches New Peripheral Angioplasty Balloon Catheters
SLEEK(TM) and SAVVY(R) Long PTA Balloon Dilatation Catheters AvailableNEW ORLEANS, La.--(HSMN NewsFeed)--Cordis Corporation (NYSE:JNJ ) announced today the U.S. launch of the SLEEK™ and SAVVY® Long PTA Balloon Dilatation Catheters, its most advanced percutaneous transluminal angioplasty (PTA) balloon catheters.
Todd M. Pope, Worldwide President, Cordis Corporation said, “These products incorporate our most advanced balloon technology and underscore our commitment to providing physicians with a full range of treatment options for patients with peripheral vascular disease.”
The SLEEKTM Balloon is one of the first .014” guidewire compatible rapid-exchange (Rx) balloons fully dedicated to infrapopliteal vessels, while the SAVVY® Long Balloon provides an .018” guidewire compatible over-the-wire (OTW) alternative for both superficial femoral and infrapopliteal arteries. With balloon lengths up to 220mm, the longest available for superficial femoral and infrapopliteal use, the SLEEKTM and SAVVY® Long Balloons may enable physicians to treat long, diffuse lesions with fewer inflations and faster procedures compared to traditional PTA balloons.
About Cordis Corporation
Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in developing and manufacturing interventional vascular and gastroenterology technology. Through research, development and innovation, physicians worldwide are better able to treat the millions of patients who require interventional procedures. For more information about Cordis, please visit www.cordis.com.
Source: Cordis
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
